References of "Alesse, E"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailSomatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
Jaffrain-Réa, ML; Rotondi, S; Turchi, A et al

in Endocrine-Related Cancer (2013), 20

Detailed reference viewed: 25 (7 ULg)
Full Text
See detailAry Hydrocarbon receptor interacting protein (AIP) on somatotroph adenomas : a molecular target for somatostatin analogues ?
JAFFRAIN-REA, M; ANGELINI, M; OCCHI, G et al

in Endocrine abstracts - May 2012, volume 29 (2012, May)

Detailed reference viewed: 24 (1 ULg)
Full Text
Peer Reviewed
See detailCaractérisation des facteurs associés à la perte d'expression de AIP dans les adénomes hypophysaires somatotropes
Jaffrain-Rea, M. L.; Angelini, M.; Tichomirowa, M. et al

in Annales d'Endocrinologie (2010, September), 71(5), 406

Detailed reference viewed: 21 (9 ULg)
See detailFactors associated with AIP expression in somatotropinomas and the possible influence of somatostatin analogues
Jaffrain-Rea, M. L.; Angelini, M.; Tichomirowa, M. et al

in European Neuroendocrine Association - Liège, 22-25 septembre 2010 (2010, September)

Detailed reference viewed: 10 (1 ULg)
Full Text
See detailCaractérisation des facteurs associés à la perte d'expression de AIP dans les adénomes hypophysaires somatotropes
Jaffrain-Rea, M.; Angelini, M.; Tichomirowa, M. et al

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 24 (13 ULg)
See detailSomatotropinomas in patients with germline AIP mutations: absence of somatic mutations in the GNAS1 gene
Angelini, M.; Annarita, T.; Tichomirowa, M. et al

in European Neuroendocrine Association - Liège, 22-25 septembre 2010 (2010, September)

Detailed reference viewed: 15 (6 ULg)
See detailScreening for AIP mutations in young patients with pituitary macroadenomas
Jaffrain-Réa, M. L.; Tichomirova, M.; Angelini, M. et al

in 5° Incontro Italiano Malattie Ipotalamo Ipofisarie (2010, January)

Detailed reference viewed: 11 (2 ULg)
Full Text
Peer Reviewed
See detailExpression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
Jaffrain-Rea, M. L.; Angelini, M.; Gargano, D. et al

in Endocrine-Related Cancer (2009), 16(3), 1029-1043

Germline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide ... [more ▼]

Germline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide further insights into the possible role of AIP in pituitary tumour pathogenesis, the expression of AIP and AHR was determined by real-time RT-PCR and/or immunohistochemistry (IHC) in a large series of PA (n=103), including 17 with AIP mutations (AIP(mut)). Variable levels of AIP and AHR transcripts were detected in all PA, with a low AHR expression (P<0.0001 versus AIP). Cytoplasmic AIP and AHR were detected by IHC in 84.0 and 38.6% of PA respectively, and significantly correlated with each other (P=0.006). Nuclear AHR was detected in a minority of PA (19.7%). The highest AIP expression was observed in somatotrophinomas and non-secreting (NS) PA, and multivariate analysis in somatotrophinomas showed a significantly lower AIP immunostaining in invasive versus non-invasive cases (P=0.019). AIP expression was commonly low in other secreting PA. AIP immunostaining was abolished in a minority of AIP(mut) PA, with a frequent loss of cytoplasmic AHR and no evidence of nuclear AHR. In contrast, AIP overexpression in a subset of NS PA could be accompanied by nuclear AHR immunopositivity. We conclude that down-regulation of AIP and AHR may be involved in the aggressiveness of somatotrophinomas. Overall, IHC is a poorly sensitive tool for the screening of AIP mutations. Data obtained on AHR expression suggest that AHR signalling may be differentially affected according to PA phenotype. [less ▲]

Detailed reference viewed: 33 (8 ULg)
See detailLa mutazione R304X del gene AIP negli adenomi ipofisari : caratteristiche bio-cliniche e aspetti genetici e funzionali
Jaffrain-Réa, M. L.; Occhi, G.; de Menis, E. et al

in 4th Incontri Italiano Sulle Malattie Ipotalamo-Ipofisarie : Ferrara 29-31 gennaio 2009 (2009, January)

Detailed reference viewed: 30 (0 ULg)
See detailAryl Hydrocarbon Receptor (AHR) and AHR Interacting Protein (AIP) expression in human GH/PRL-secreting pituitary adenomas
Jaffrain-Réa, M. L.; Gargano, D.; D'Innocenzo, E. et al

in Italian Congress of Endocrinology - Giornate Endocrinologiche Pisane GEP 2008 : Pisa 2008 (2008)

Detailed reference viewed: 13 (4 ULg)
See detailAryl Hydrocarbon receptor interacting protein (AIP) expression in human pituitary adenomas
Jaffrain-Rea, M. L.; Spilioti, C.; Vanbellinghen, Jean-François ULg et al

in 10th European Congress of Endocrinology - Abstract book (2008)

Detailed reference viewed: 1 (0 ULg)